Lifevantage Corporation (LFVN) - Net Assets
Based on the latest financial reports, Lifevantage Corporation (LFVN) has net assets worth $33.59 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($62.11 Million) and total liabilities ($28.52 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Lifevantage Corporation PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $33.59 Million |
| % of Total Assets | 54.08% |
| Annual Growth Rate | 21.12% |
| 5-Year Change | 6.58% |
| 10-Year Change | 131.22% |
| Growth Volatility | 9139.18 |
Lifevantage Corporation - Net Assets Trend (1997–2026)
This chart illustrates how Lifevantage Corporation's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Lifevantage Corporation (LFVN) market capitalisation.
Annual Net Assets for Lifevantage Corporation (1997–2026)
The table below shows the annual net assets of Lifevantage Corporation from 1997 to 2026. Also explore how fast is Lifevantage Corporation growing its equity to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-06-30 | $33.59 Million | -3.04% |
| 2025-06-30 | $34.64 Million | +33.28% |
| 2024-06-30 | $25.99 Million | -24.99% |
| 2023-06-30 | $34.65 Million | +9.94% |
| 2022-06-30 | $31.52 Million | -14.37% |
| 2021-06-30 | $36.81 Million | +10.68% |
| 2020-06-30 | $33.25 Million | +22.26% |
| 2019-06-30 | $27.20 Million | +23.93% |
| 2018-06-30 | $21.95 Million | +51.08% |
| 2017-06-30 | $14.53 Million | +19.75% |
| 2016-06-30 | $12.13 Million | +264.84% |
| 2015-06-30 | $3.33 Million | -16.67% |
| 2014-06-30 | $3.99 Million | -88.25% |
| 2013-06-30 | $33.95 Million | +20.02% |
| 2012-06-30 | $28.28 Million | +235.92% |
| 2011-06-30 | $-20.81 Million | -28.64% |
| 2010-06-30 | $-16.17 Million | -135.99% |
| 2009-06-30 | $-6.85 Million | -316.27% |
| 2008-06-30 | $3.17 Million | +16.80% |
| 2007-06-30 | $2.71 Million | -67.25% |
| 2006-06-30 | $8.28 Million | -24.53% |
| 2005-06-30 | $10.98 Million | +46633.27% |
| 2004-06-30 | $23.49K | -20.97% |
| 2003-06-30 | $29.72K | -22.11% |
| 2002-06-30 | $38.16K | +224.99% |
| 2000-06-30 | $11.74K | -56.42% |
| 1999-06-30 | $26.95K | -74.50% |
| 1998-06-30 | $105.66K | -18.53% |
| 1997-06-30 | $129.70K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Lifevantage Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 10346200000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2026)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.00K | 0.00% |
| Other Comprehensive Income | $-1.87 Million | -5.58% |
| Other Components | $138.92 Million | 413.60% |
| Total Equity | $33.59 Million | 100.00% |
Lifevantage Corporation Competitors by Market Cap
The table below lists competitors of Lifevantage Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Daemyung Sonoseason Co.Ltd
KQ:007720
|
$77.67 Million |
|
Aerovate Therapeutics Inc
NASDAQ:AVTE
|
$77.68 Million |
|
PolyPid
NASDAQ:PYPD
|
$77.73 Million |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
$77.76 Million |
|
Asetek A/S
F:A31
|
$77.66 Million |
|
MAIA Biotechnology Inc.
NYSE MKT:MAIA
|
$77.66 Million |
|
Novonix Ltd
AU:NVX
|
$77.65 Million |
|
Wintergreen Acquisition Corp. Ordinary Shares
NASDAQ:WTG
|
$77.62 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lifevantage Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 34,641,000 to 33,589,000, a change of -1,052,000 (-3.0%).
- Net income of 5,072,000 contributed positively to equity growth.
- Dividend payments of 2,344,000 reduced retained earnings.
- Share repurchases of 2,043,000 reduced equity.
- Other comprehensive income decreased equity by 699,000.
- Other factors decreased equity by 1,038,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $5.07 Million | +15.1% |
| Dividends Paid | $2.34 Million | -6.98% |
| Share Repurchases | $2.04 Million | -6.08% |
| Other Comprehensive Income | $-699.00K | -2.08% |
| Other Changes | $-1.04 Million | -3.09% |
| Total Change | $- | -3.04% |
Book Value vs Market Value Analysis
This analysis compares Lifevantage Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.34x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.69x to 2.34x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1997-06-30 | $1.09 | $6.20 | x |
| 1998-06-30 | $0.89 | $6.20 | x |
| 1999-06-30 | $0.23 | $6.20 | x |
| 2000-06-30 | $0.10 | $6.20 | x |
| 2001-06-30 | $0.34 | $6.20 | x |
| 2002-06-30 | $0.28 | $6.20 | x |
| 2003-06-30 | $0.21 | $6.20 | x |
| 2004-06-30 | $0.17 | $6.20 | x |
| 2005-06-30 | $4.37 | $6.20 | x |
| 2006-06-30 | $2.62 | $6.20 | x |
| 2007-06-30 | $0.85 | $6.20 | x |
| 2008-06-30 | $0.98 | $6.20 | x |
| 2009-06-30 | $-1.19 | $6.20 | x |
| 2010-06-30 | $-1.97 | $6.20 | x |
| 2011-06-30 | $-1.99 | $6.20 | x |
| 2012-06-30 | $1.67 | $6.20 | x |
| 2013-06-30 | $1.93 | $6.20 | x |
| 2014-06-30 | $0.25 | $6.20 | x |
| 2015-06-30 | $0.23 | $6.20 | x |
| 2016-06-30 | $0.83 | $6.20 | x |
| 2017-06-30 | $1.03 | $6.20 | x |
| 2018-06-30 | $1.55 | $6.20 | x |
| 2019-06-30 | $1.82 | $6.20 | x |
| 2020-06-30 | $2.28 | $6.20 | x |
| 2021-06-30 | $2.58 | $6.20 | x |
| 2022-06-30 | $2.41 | $6.20 | x |
| 2023-06-30 | $2.76 | $6.20 | x |
| 2024-06-30 | $2.00 | $6.20 | x |
| 2025-06-30 | $2.67 | $6.20 | x |
| 2026-06-30 | $2.64 | $6.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lifevantage Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 15.10%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.78%
- • Asset Turnover: 2.94x
- • Equity Multiplier: 1.85x
- Recent ROE (15.10%) is above the historical average (-3.72%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1997 | -15.30% | 0.00% | 0.00x | 2.38x | $-32.81K |
| 1998 | -22.75% | 0.00% | 0.00x | 2.92x | $-34.60K |
| 1999 | -292.10% | 0.00% | 0.00x | 6.80x | $-81.41K |
| 2000 | -129.47% | -1520400.00% | 0.00x | 3.04x | $-16.38K |
| 2001 | -56.19% | -2473000.00% | 0.00x | 1.00x | $-29.13K |
| 2002 | -42.84% | 0.00% | 0.00x | 1.03x | $-20.17K |
| 2003 | -31.73% | 0.00% | 0.00x | 1.23x | $-12.40K |
| 2004 | -52.11% | 0.00% | 0.00x | 1.62x | $-14.59K |
| 2005 | -53.04% | -247.36% | 0.20x | 1.08x | $-6.92 Million |
| 2006 | -33.01% | -38.16% | 0.69x | 1.26x | $-3.56 Million |
| 2007 | -136.12% | -73.13% | 1.29x | 1.44x | $-3.96 Million |
| 2008 | -64.82% | -64.20% | 0.70x | 1.44x | $-2.37 Million |
| 2009 | 0.00% | -220.09% | 0.72x | 0.00x | $-8.43 Million |
| 2010 | 0.00% | -96.25% | 1.84x | 0.00x | $-9.43 Million |
| 2011 | 0.00% | -130.51% | 3.11x | 0.00x | $-48.71 Million |
| 2012 | 44.09% | 9.88% | 2.83x | 1.57x | $9.64 Million |
| 2013 | 22.41% | 3.65% | 3.75x | 1.63x | $4.21 Million |
| 2014 | 285.29% | 5.32% | 3.96x | 13.53x | $10.98 Million |
| 2015 | 210.14% | 3.67% | 4.66x | 12.29x | $6.65 Million |
| 2016 | 49.62% | 2.91% | 4.11x | 4.14x | $4.81 Million |
| 2017 | 11.07% | 0.81% | 4.41x | 3.11x | $155.30K |
| 2018 | 26.25% | 2.84% | 3.97x | 2.33x | $3.57 Million |
| 2019 | 27.31% | 3.29% | 4.09x | 2.03x | $4.71 Million |
| 2020 | 34.73% | 4.96% | 3.96x | 1.77x | $8.22 Million |
| 2021 | 35.03% | 5.86% | 2.80x | 2.14x | $9.21 Million |
| 2022 | 9.90% | 1.51% | 2.92x | 2.24x | $-31.60K |
| 2023 | 7.33% | 1.19% | 3.23x | 1.91x | $-924.90K |
| 2024 | 11.30% | 1.47% | 3.32x | 2.32x | $337.90K |
| 2025 | 28.30% | 4.29% | 3.18x | 2.08x | $6.34 Million |
| 2026 | 15.10% | 2.78% | 2.94x | 1.85x | $1.71 Million |
Industry Comparison
This section compares Lifevantage Corporation's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $169,127,121
- Average return on equity (ROE) among peers: -13.13%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lifevantage Corporation (LFVN) | $33.59 Million | -15.30% | 0.85x | $77.67 Million |
| Above Food Ingredients Inc. Common Stock (ABVE) | $199.86 Million | -2.89% | 0.00x | $4.86 Million |
| Agape ATP Corporation Common Stock (ATPC) | $3.31 Million | -76.20% | 0.43x | $2.34 Million |
| B&G Foods Inc (BGS) | $835.46 Million | -7.92% | 3.15x | $244.45 Million |
| BioHarvest Sciences Inc. Common Stock (BHST) | $-59.57K | 0.00% | 0.00x | $36.27 Million |
| BranchOut Food Inc. Common Stock (BOF) | $-5.14 Million | 0.00% | 0.00x | $59.67 Million |
| Bellring Brands LLC (BRBR) | $-161.00 Million | 0.00% | 0.00x | $1.06 Billion |
| BRC Inc. (BRCC) | $95.94 Million | -86.42% | 1.35x | $216.27 Million |
| BRF SA ADR (BRFS) | $672.80 Million | 25.01% | 2.60x | $5.38 Billion |
| Bridgford Foods Corporation (BRID) | $50.80 Million | 17.13% | 0.49x | $53.01 Million |
| Borealis Foods Inc. (BRLS) | $-695.89K | 0.00% | 0.00x | $29.83 Million |
About Lifevantage Corporation
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Om… Read more